Results for tag: "Neuroprotection Drug"

The Neuroprotection Drug market is a subset of Central Nervous System Drugs, which are used to treat a variety of neurological conditions. Neuroprotection drugs are used to protect the brain and spinal cord from damage caused by trauma, stroke, and other neurological diseases. These drugs can also be used to reduce the risk of developing certain neurological disorders, such as Alzheimer's disease. Neuroprotection drugs are typically administered orally, intravenously, or intramuscularly. Neuroprotection drugs are used to reduce inflammation, improve blood flow, and protect neurons from damage. They can also be used to reduce the risk of developing certain neurological disorders, such as Parkinson's disease. Additionally, these drugs can be used to improve cognitive function and reduce the risk of developing dementia. Some companies in the Neuroprotection Drug market include AbbVie, AstraZeneca, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more